Reduced pericytes' coverage of endothelium in the brain is one of the structural changes leading to breach of the blood-brain barrier during HIV infection. We previously showed in central memory T (T CM ) cells that HIV latency increases cellular susceptibility to DNA damage. In this study, we investigated susceptibility of primary brain pericytes infected with HIV-1 to DNA damage in response to glutamate and TNF-α, both known to induce neuronal death during chronic inflammatory conditions. To infect pericytes, we used a single-cycle HIV-1 pseudotyped with VSV-G envelope glycoprotein and maintained the cultures until latency was established. Our data indicate that pericytes silence HIV-1 expression at similar rate compared to primary T CM cells. TNF-α and IL-1β caused partial reactivation of the virus suggesting that progression of disease and neuroinflammation might facilitate virus reactivation from latency. Significant increases in the level of γH2AX, which reflect DNA damage, were observed in infected cultures exposed to TNF-α and glutamate at day 2 post-infection. Glutamate, an excitatory neurologic stimuli, also caused increases in the γH2AX level in latently infected pericytes, whereas PARP and DNA-PK inhibitors caused reductions in cell population suggesting that HIV-1 latency affects repairs of single-and double-strand DNA breaks. For comparison, we also analyzed latently infected astrocytes and determined that DNA damage response in astrocytes is less affected by HIV-1. In conclusion, our results indicate that productive infection and HIV-1 latency in pericytes interfere with DNA damage response, rendering them vulnerable to the agents that are characteristic of chronic neuroinflammatory disease conditions.
Introduction
Pericytes have a crucial role in the formation and maintenance of the blood-brain barrier (BBB) integrity and are also important mediators of neuroinflammation (Cho et al. 2017; Jansson et al. 2014; Rustenhoven et al. 2017) . Their significance to BBB function is also highlighted by increased density of pericytes covering the central nervous system (CNS) vasculature, when compared to capillaries and venules in other parts of the body (Aguilera and Brekken 2014; Armulik et al. 2010; Bell et al. 2010) . The pericytes' coverage is reduced in diseases characterized by BBB impairment, such as Alzheimer's disease (AD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and also HIV-associated neurocognitive disorders (HAND) (Aguilera and Brekken 2014; Persidsky et al. 2016; Sengillo et al. 2013; Winkler et al. 2013) . Chronic neuroinflammation associated with these diseases causes pericyte dysfunction characterized by changes in their phenotype leading to detachment from endothelial cells, reduced expression of factors promoting BBB formation and integrity, and increased expression of molecules promoting monocyte infiltration (Jansson et al. 2014; Persidsky et al. 2016; Rustenhoven et al. 2017) . All these contribute to increased leakage through the BBB.
HIV-1 invades the CNS early after the initial infection and contributes to development of neuroinflammation. The condition is characterized by chronically increased levels of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), and excess extracellular glutamate and nitric oxide (NO) (Brahmachari et al. 2006; Holguin et al. 2004; Saylor et al. 2016 ). Viral proteins Tat and envelope glycoprotein gp120 have been shown to affect glutamate homeostasis (Haughey et al. 2001; Melendez et al. 2016; Musante et al. 2010; Potter et al. 2013; Vesce et al. 1997) . Tat was also found to induce changes in pericytes resulting in increased cell migration suggesting that the loss of pericyte coverage in the BBB during HAND is due to their detachment from endothelium (Niu et al. 2014) .
The major cells in the CNS supporting HIV-1 replication are microglia and macrophages, but the virus also has an ability to infect pericytes and astrocytes, and although at a low level, their infection was found to disrupt the integrity of the endothelial barrier (Cho et al. 2017; Churchill et al. 2006; Eugenin et al. 2011; Nakagawa et al. 2012 ; Thompson et al. 2011; Tornatore et al. 1994; Wiley et al. 1986 ). Permissiveness of pericytes to non-productive HIV-1 infection suggests that the cells might support viral latency. We and others showed that HIV-1 affects DNA damage response (DDR) in cells during virus expression, as well as during latency (Belzile et al. 2010; Piekna-Przybylska et al. 2017; Roshal et al. 2003; Sun et al. 2006; Zhu et al. 2001; Zimmerman et al. 2004) . We hypothesize that the loss of pericyte coverage in brains of patients with HAND is also related to an increased death rate of infected pericytes due to higher susceptibility to oxidative stress induced by chronic neuroinflammation, particularly glutamate and TNF-α. Chronic excess of extracellular glutamate during neuroinflammation is well known to act as a neurotoxin, which triggers oxidative stress and DNA damage leading to neuronal death (Lau and Tymianski 2010) . TNF-α is also a key player in neuronal death during inflammatory disease states (Liu et al. 2014; Tweedie et al. 2007; Zou and Crews 2005) .
In order to determine susceptibility of HIV-1-infected pericytes to neuroinflammatory conditions, we analyzed the level of DNA damage in response to pro-inflammatory cytokine TNF-α and to glutamate soon after infection and during latency. For comparison, we also analyzed infected astrocytes. We show that pericytes, and also astrocytes, can efficiently silence HIV-1 expression at a similar rate as primary central memory T (T CM ) cells, and that the viral latency renders pericytes sensitive to the excess of extracellular glutamate. By exposing latently infected cultures to DDR inhibitors, we determined that HIV latency affected more pericytes than astrocytes, in repairs of single-(SSBs) and double-strand DNA breaks (DSBs).
Results
Productively infected primary brain pericytes are susceptible to glutamate and TNF-α
To investigate the effect of neuroinflammatory conditions on infected brain pericytes, we used primary human brain vascular pericytes and infected them with HIV-1 NL4-3 strain. We used single-cycle virus (DHIV) with defective env, which precludes production of infectious viral particles after a single round of infection. We also used HIV-1 NL4-3 engineered to encode green fluorescent protein (GFP) as a transcriptional reporter of virus genes (HIV-GFP). Since permissiveness of pericytes to HIV infection is low, we used VSV-G env for pseudotyping HIV to increase efficiency of virus entry into the cell. VSV-G env has broad tropism and is used with HIV vectors and other retroviruses to increase population of infected cells in a culture.
For HIV-1 infection, primary brain pericytes were seeded to achieve 80-90% confluency and then exposed to HIV-GFP or DHIV (both at 10 ng/ml of p24) for 24 h. On day 1 postinfection (1 dpi), we observed small population of GFPpositive or p24-positive cells (not shown), but at 2 dpi, almost entire population expressed GFP (Fig. 1a) , or stained positively for p24 (Fig. 1b) . Using Vi-CELL counter and fluorescent microscope, we determined that the number of cells in infected population was reduced by about 50% at 2-3 dpi (see Fig. 2a ), whereas immunofluorescent staining showed the presence of gamma-H2AX (γH2AX) foci in nuclei, indicating phosphorylation of histone H2A variant in response to DNA damage (Fig. 1a) . Since single-cycle virus cannot produce new viral particles, the reduction in pericyte population could be due to their sensitivity to the expression of viral proteins and resulted from cell cycle arrest and apoptosis (Badley et al. 2000; Cummins and Badley 2010; de Silva et al. 2012; Herbein et al. 1998; Piekna-Przybylska and Maggirwar 2018; Planelles et al. 1995; Tachiwana et al. 2006) .
The γH2AX protein is a marker of DSB formation, in response to signaling events triggered by multiple forms of DNA damages, like oxidative DNA damage, formation of covalent DNA adducts, replication stress, and formation of SSBs (Guo et al. 2010; Khoronenkova and Dianov 2015; Olive 2009; Yan et al. 2011; Yan et al. 2014) . Therefore, the effects of extracellular glutamate and TNF-α on DDR in pericytes were analyzed by monitoring the level of γH2AX. At day 1 post-infection, we exposed uninfected and DHIVinfected cells to glutamate (250 nM), or TNF-α (75 ng/ml), and 24 h later (2 dpi), we analyzed the γH2AX levels by fluorescent microscope. Since infected cells showed reduction in cell numbers (about 50%), we compared the levels of γH2AX by calculating average fluorescence intensities of Alexa Fluor 647 used to detect γH2AX. Data were normalized to basal level of fluorescence calculated for uninfected and untreated pericytes (Fig. 1b) . Glutamate and TNF-α treatment caused 10-20% increases in fluorescence intensity of the γH2AX signals for uninfected cells, when compared to untreated cultures. For DHIV-infected pericytes, there were 20-30% increases in intensity of the γH2AX signals, but up to 50% for infected cells exposed to glutamate and TNF-α. These increases also correlated with reduction in the number of cells, especially for cells treated with glutamate for both infected and uninfected pericytes. The results, summarized in Fig. 2a , show that in reference to untreated and uninfected pericytes, DHIV infection reduced pericyte population to 52 ± 2.9%. This reduction likely results from HIV-induced cell cycle arrest and apoptotic cell death. In reference to untreated The effects of TNF-α and glutamate on DNA damage in pericytes infected with DHIV. Pericytes were exposed to DHIV for 24 h, then the virus was removed and cells were incubated with TNF-α (75 ng/ml) or glutamate (250 nM) for another 24 h. The level of DNA damage was analyzed by calculating the level of γH2AX using fluorescent microscopy. Top left, fluorescent microscope image showing detection of p24 Gag in a culture of pericytes stained with p24-FITC (green) at day 2 post-infection. Top right, the graph shows relative increases in fluorescence intensities of Alexa Fluor 647 conjugated with monoclonal antibodies detecting phosphorylated H2A (AF 647 -γH2AX) for infected pericytes (Per/DHIV) treated with TNF-α (TNF) or glutamate (GLU), in reference to uninfected and untreated (NT) cultures. Bottom, representative fluorescent microscope images showing increases in γH2AX signaling in response to glutamate and TNF-α in uninfected and infected pericytes. A magnified view of the boxed region is shown below. Arrows show γH2AX foci. Statistical analysis was done by oneway ANOVA and Tukey's multiple comparisons post-test (significance *, P< 0.05, **, P < 0.01, ****, P < 0.0001). Differences in respect to untreated (NT) and uninfected pericytes (Per). Differences between Per/ DHIV and Per/DHIV treated with TNF and GLU are also indicated cultures (Fig. 2b) , TNF-α caused reductions in cell number to 92.3 ± 2.9% for uninfected pericytes and to 87.6 ± 8% for DHIV-infected pericytes. This difference was not statistically significant. However, for cells treated with glutamate, there were reductions in the cell number to 74.4 ± 9.1% and to 58.5 ± 5.6% for uninfected and DHIV-infected cultures, respectively. Thus, although TNF-α treatment also induced formation of ɣH2AX, it had a smaller effect on the cell number. In conclusion, these results suggest that upon HIV-1 infection, b r a i n p e r i c y t e s b e c o m e m o r e s u s c e p t i b l e t o neuroinflammatory mediators.
The rate of HIV-1 latency in primary human brain pericytes is comparable to that in central memory T cells
To determine whether pericytes support HIV latency, the cultures of infected pericytes were maintained for a period of 11-13 days post-infection and monitored for virus expression. Application of the virus with defective env precluded production of infectious viral particles after a single round of infection, while pseudotyping HIV-1 with VSV-G envelope protein allowed infection of entire population. Since virus did not spread in the cell culture, we were able to determine how efficiently pericytes can silence HIV-1 expression once they are infected. The HIV-1 silencing was monitored by flow cytometry and microscopic imaging of the GFP or p24 expression following infections with HIV-GFP and DHIV, respectively. The rate of HIV-1 silencing in pericytes was also compared with that in T CM cells. In this case, the T CM cells were infected with HIV-GFP and DHIV in an analogous manner. As shown in Fig. 3a , b, cultivation of primary brain pericytes infected with HIV-GFP or DHIV led to a dramatic loss of HIV-1 expression over a period of 1 week. About 5% of pericyte population were GFP positive at day 1 post-infection. By day 2-3 post-infection, over 80% of pericytes turned GFP positive, and this population was reduced by a half by day 5-6 post-infection (2-3 days later). By day 11-12 post-infection, the GFP-positive population was only about 2% (not shown). Integration of provirus into the host genome was confirmed by Alu-gag polymerase chain reaction (PCR) followed by nested PCR reactions using genomic DNA isolated from cells collected at day 11 post-infection ( Fig. 3c) . A small population of GFP-negative cells at 3 dpi likely represent cells that were GFP-positive at 1-2 dpi that had already silenced virus expression. We observed similar flow cytometry profiles for cells infected with larger quantities of virus. Quick silencing of virus expression indicates that cellular environment in brain pericytes helps to enforce virus latency. This observation is consistent with previous reports indicating that HIV-1 does not propagate well in pericyte cultures (Nakagawa et al. 2012) .
In addition to TNF-α, development of neuroinflammation during HIV infection is associated with increased expression of interleukin-1 beta (IL-1β), interferon gamma (IFN-γ), and IL-6. Among these, TNF-α, IL-1β, and IL-6 were found to have an ability to reactivate latent virus in T cells or macrophages (Chun et al. 1998; Devadas et al. 2004; Granowitz et al. 1995; Oguariri et al. 2007; Poli et al. 1994; Saleh et al. 2011) . To test whether latent HIV-1 can be reactivated in pericytes, on day 10 post-infection, the cells were exposed to TNF-α (50 ng/ml) together with IL-1β (50 ng/ml) for 24 h. Flow cytometric analyses showed that TNF-α + IL-1β treatment increased the GFP-positive population in latently infected pericyte cultures from about 3 to 11% (Fig. 3d ). This suggests that the accumulation of pro-inflammatory milieu in the brain might induce HIV reactivation from latency in pericytes and drive replication of the virus at a low level.
Next, we analyzed the rate of HIV-1 silencing in pericytes by comparing it with the rate observed in T CM cells infected by the same virus. It is noteworthy that the T CM cells constitute the major HIV-1 reservoir known to support viral latency (Soriano-Sarabia et al. 2014) . We first selected primary naïve CD4 + T cells from peripheral blood mononuclear cells Fig. 2 Reductions in the number of pericytes are observed after HIV-1 infection and treatment with TNF-α or glutamate. a Graph corresponding to three experiments shows reductions in cell number in reference to untreated and uninfected pericytes. Number of cells was calculated using fluorescent microscope by counting DAPI-stained nuclei. b Graph corresponding to three experiments shows the effect of HIV-1 infection on increased susceptibility to glutamate treatment. Reductions in the number of cells were calculated in reference to untreated cultures (NT, dashed line). Statistical analysis was done by one-way ANOVA and Tukey's multiple comparisons post-test (significance was set at P < 0.05, **, P < 0.01, ***, P < 0.001, ****, P < 0.0001). Differences with respect to untreated (NT) and uninfected pericytes (Per). Differences between uninfected (Per) and infected (Per/DHIV) treated with TNF and GLU are also indicated (PBMC) and primed them towards differentiation into nonpolarized (NP) cells, which resemble the phenotype of the T CM cells (Fig. 3e ) (Bosque and Planelles 2009; PieknaPrzybylska et al. 2017) . Infections with HIV-1 were performed when cells were still in an activated stage, and latency was established by progression of activated cells to a quiescent, memory-like stage. As shown in Fig. 3f , g, by day 3 postinfection, about 20% of population were GFP positive, and this population was reduced by half on day 5-6 post-infection (2-3 days), similar to what was observed for infected pericytes. Cells returned to a quiescent stage by day 11-12 post-infection. This observation is also consistent with a rate of HIV silencing in primary memory T cells when latency is established with replication-competent virus in the presence of combination antiretroviral therapy (cART) (Martins et al. 2016) , and indicates that HIV-1 expression is silenced in pericytes in similar time frame, and at similar rate as in T CM cells.
HIV-1 latency in brain vascular pericytes affects cellular DDR to glutamate
To determine the sensitivity of latently infected pericytes to the inflammatory molecules, at day 10 post-infection (DHIV), cells were collected and counted to seed equal number of cells in new dishes. The next day, we treated cells with 250 nM By day 7 post-infection, most of pericytes turn negative for HIV expression. Nuclei were counterstained with DAPI (blue). c Detection of integrated HIV-1 provirus in pericytes by Alu-gag PCR followed by the nested PCR. Agarose gel shows amplified products in the nested PCR with primers specific for U3, R, U5, and UTR gag regions of HIV-1. The 411 nt product A was amplified using primers specific for U3 (NF-κ3 region) and UTR gag; the B product (330 nt)-U3 (Sp1 region) and UTR gag; the C product (140 nt)-R and U5. d The effect of pro-inflammatory conditions on virus reactivation from latency was analyzed on day 11 post-infection. Latently infected pericytes showed increases in GFP population after treating cells with TNF-α (50 ng/ml) and IL-1β (50 ng/ml) for 24 h. glutamate for 24 h and analyzed the level of γH2AX by flow cytometry. No differences in cell numbers were observed for glutamate-treated cultures. However, the results summarized in Fig. 4 show that infected pericytes exposed to glutamate have greater increases in the γH2AX levels. Elevated glutamate during chronic neuroinflammation is known to be associated with mitochondrial dysfunction and oxidative stress that generates sufficient reactive oxygen species (ROS) to cause DNA damage (Kritis et al. 2015) . The damage from ROS is likely to be a mixture of oxidative damage to DNA bases, SSBs, and DSBs. Thus, increases in the level of γH2AX in response to glutamate would indicate that DNA repairs induced by ROS are not processed efficiently in infected cells. Base excision repair (BER) pathway, which processes oxidative DNA damage, transiently generates abasic sites that can be converted to SSBs and DSBs (Sczepanski et al. 2010) . Therefore, we also analyzed efficiency of DDR in latently infected pericytes by targeting poly adenosine diphosphate [ADP] ribose polymerases (PARP), DNA-dependent protein kinase (DNA-PK), and protein kinase ataxia-telangiectasia mutated (ATM), the factors that are intimately involved in repairs of SSBs and DSBs. PARP is a family of enzymes involved in the repair of SSB and assists in repairs of nicks generated as a result of BER (Ame et al. 2004; Schreiber et al. 2002) . This enzyme is also involved in repairs of DSBs (Beck et al. 2014) . DNA-PK is required for the repairs of DSBs through non-homologous end joining (NHEJ) pathway and maintenance of telomeres (Davis et al. 2014; Gilley et al. 2001; Williams et al. 2009 ). ATM is well known for its role in activating the DDR due to formation of DSBs (Bakkenist and Kastan 2003; Ward et al. 2001) . At day 10 post-infection, equal number of latently infected and uninfected pericytes was seeded on new dishes, and 24 h later, the cultures were exposed to 3-ABA (6 mM), NU7441
(1 μM), or KU55933 (1 μM), which are the inhibitors of PARP, DNA-PK, and ATM, respectively. After 30 h of treatment, we analyzed the number of cells and their viability by using Vi-CELL counter or fluorescent microscope. The results, summarized in Fig. 5 , show that there was no significant difference between cultures of infected and uninfected pericytes treated with ATM inhibitor. However, inhibitors of DNA-PK and PARP reduced population of latent cells for about 19 ± 4% and 40 ± 6%, respectively, when compared to uninfected pericytes treated with these inhibitors. In conclusion, increased cytotoxic effects of DDR inhibitors for latently infected cells indicate that HIV latency established in brain pericytes may affect cell ability to efficiently respond to DNA damage induced by the excess of extracellular glutamate.
Primary cultures of pericytes and astrocytes are differentially affected by HIV-1 latency For comparison, we also analyzed DDR in infected primary brain astrocytes to evaluate increased susceptibility of HIV-1-infected pericytes to neuroinflammatory conditions. Using the same approach described for pericytes, we established infections in astrocytes isolated from cerebral cortex and observed similar rate of HIV-1 silencing. By day 2-3 post-infection, over 90% of astrocytes turned GFP positive, and this population was reduced to about 40% by day 7 post-infection and to only about 10% by day 10 (Fig. 6a) . Cultures of uninfected and latently infected astrocytes were then used to analyze the effects induced by glutamate and inhibitors of PARP, DNA-PK, and ATM, using the same conditions as for pericytes.
The results, summarized in Fig. 6b , show that about 10 ± 3% of infected astrocytes stained positively for the presence of γH2AX, and it increased to 17 ± 3% following their exposure Fig. 4 Effect of glutamate on primary brain vascular pericytes latently infected HIV-1. At day 11 post-infection, DHIV-infected pericytes were exposed to glutamate (250 nM) for 24 h and analyzed by flow cytometry for the level of γH2AX. Representative flow cytometry plots showing the level of γH2AX in uninfected and latently infected pericytes (+ DHIV) and after glutamate (GLU) treatment. The gate represents the plot area with the highest fluorescence intensity of Alexa Fluor 647 detecting γH2AX in cells. The numbers indicate the percentage of the γH2AX-positive events recorded in the gate. On the right, the graph corresponding to three experiments shows increases in the γH2AX level in uninfected (Per) and latently infected pericytes (Per/DHIV), and in response to glutamate treatment. NT not treated cells. Statistical analysis was done by one-way ANOVA and Tukey's multiple comparisons post-test (significance *, P < 0.05, **, P < 0.01). Differences with respect to untreated (NT) and uninfected pericytes (Per). Difference between untreated (NT) Per/DHIV and treated with GLU is also indicated to 250 nM glutamate. For uninfected cultures, the background level of γH2AX was 3.5 ± 1.8%, and it increased to 7 ± 2.5% after glutamate treatment. For cultures exposed to inhibitors, we analyzed the cell numbers using Vi-CELL counter and fluorescent microscope. The results, summarized in Fig. 6c , show that population of latently infected astrocytes was less affected by DDR inhibitors, as we observed for latently infected pericytes (Fig. 5) . When compared to uninfected astrocytes, there was about 7 ± 4.1% reduction in cell population of latently infected astrocytes in cultures exposed to 1 μM NU7441 and about 11 ± 6.1% reduction in cultures exposed to 6 mM 3-ABA.
Taken together, our results indicate that latently infected pericytes are more susceptible to DDR inhibitors, as opposed to latently infected astrocytes, and thus suggest that DDR in pericytes is less efficient after HIV-1 infection. Therefore, reduced ability to perform DNA repairs would predispose pericytes to cytotoxic effects of excessive glutamate implicated in neuronal injury in many disorders of CNS, including HAND (Vazquez-Santiago et al. 2014) .
Discussion
Inflammation in the CNS is associated with chronic oxidative stress, a key feature of all neurodegenerative diseases, including HAND (Ferrell and Giunta 2014; Scutari et al. 2017 ). The condition results from progressive loss of neurons due to oxidative stress-mediated DNA damage triggered by excess of extracellular glutamate, nitric oxide (NO), and sustained release of inflammatory mediators, such as TNF-α, IL-1β, and IFN-γ (Brabers and Nottet 2006; Ferrarese et al. 2001; Tavazzi et al. 2014) . In addition to loss of neurons, recent studies show that brain pericyte coverage is diminished in HIV-infected patients with or without combination antiretroviral therapy (cART) (Persidsky et al. 2016 ). Proinflammatory cytokines are indicated as major contributors of pericyte depletion during chronic neuroinflammation that results from pericyte detachment and migration from BBB (Jansson et al. 2014; Persidsky et al. 2016; Rustenhoven et al. 2017) . In these studies, we investigated whether diminished coverage of pericytes in the brain of HIV-infected patients could be also associated with increased susceptibility of infected pericytes to neuroinflammatory conditions.
We recently reported that HIV-1 latency in T CM cells affects cellular DDR and results in increased susceptibility to DNA damage (Piekna-Przybylska et al. 2017) . Pericytes are permissive to HIV-1 infection, although the rate of virus replication appears to be even lower than in astrocytes, where HIV-1 replication is also restricted (Nakagawa et al. 2012) . Nevertheless, low level of HIV-1 replication also suggests that after infection, the cells can suppress virus expression and promote viral latency. Since chronic neuroinflammation induces DNA damage in neurons and leads to their death, and HIV-1 has ability to interfere with cellular DDR, we considered that depletion of pericytes in the brain also results from increased susceptibility to neuroinflammation when pericytes are infected. Our data indicate that pericytes, and also astrocytes, can efficiently silence HIV-1 expression, suggesting that these cells support HIV-1 latency in the brain. The ability of TNF-α and IL-1β to reactivate HIV-1 in pericytes also suggests that the progression of HAND disease, characterized by sustained release of pro-inflammatory factors in the CNS, may stimulate virus reactivation by terminating latency. Reductions in cell number observed at day 2-3 postinfection likely result from two factors, one is cell cycle arrest and another is apoptosis. Cell death related to HIV infection is well documented. Most of HIV-infected cells undergo apoptotic cell death following infection, and it is associated with proapoptotic qualities of viral proteins gp120, Tat, Nef, Vpr, Vpu, and HIV protease (Badley et al. 2000; Cummins and Badley 2010; de Silva et al. 2012; Herbein et al. 1998 ; Planelles et al. 1 μM) , DNA-PK (NU7441, 1 μM), and PARP (3-ABA, 6 mM) for 30 h and the number of cells was calculated using fluorescent microscope and Vi-CELL counter. Graphs corresponding to three experiments show that significant reductions in cell population are observed for latently infected pericytes (DHIV) exposed to inhibitor targeting PARP involved in SSB repair and to inhibitor targeting DNA-PK involved in DSB repair. Statistical analysis was done by one-way ANOVA and unpaired t test analysis (significance *, P < 0.05, **, P < 0.01, ****, P < 0.0001). Left graph, differences with respect to untreated (NT) cells. Right graph, differences between uninfected and infected (DHIV) treated with different drugs 1995; Tachiwana et al. 2006) . Infected primary CD4 + T cells undergo increased rate of apoptosis after HIV infection (Piekna-Przybylska and Maggirwar 2018). The apoptosis is also induced by HIV reactivation in primary memory T cells and in T cell lines even for latent cells established with defective viruses which cannot produce viral particles (Piekna-Przybylska and Maggirwar 2018).
Chronic excess of extracellular glutamate acts as a neurotoxin. It is a well-known trigger of calcium influx in neurons leading to their mitochondrial dysfunction, ROS generation, and after glutamate (GLU) treatment. On the right, the graph corresponding to three experiments shows increase in the γH2AX level in uninfected (HA) and latently infected astrocytes (HA/DHIV), and in response to glutamate treatment. NT not treated cells. Statistical analysis was done by one-way ANOVA and Tukey's multiple comparisons post-test (significance *, P < 0.05, **, P < 0.01). Differences with respect to untreated (NT) and uninfected astrocytes (HA). Difference between untreated (NT) HA/DHIV and treated with GLU is also indicated. c At day 11 postinfection, astrocytes were exposed to inhibitors of ATM (KU55933, 1 μM), DNA-PK (NU7441, 1 μM), and PARP (3-ABA, 6 mM) for 30 h and the number of cells was calculated using fluorescent microscope and Vi-CELL counter. Graphs corresponding to three experiments show effects of DNA repair inhibitors on population of latently infected astrocytes (DHIV). Statistical analysis was done by one-way ANOVA and unpaired t test analysis (significance *, P < 0.05, ***, P < 0.001, ****, P < 0.0001). Left graph, differences with respect to untreated (NT) cells. Right graph, differences between uninfected and infected (DHIV) treated with different drugs oxidative DNA damage, and finally cell death (Kritis et al. 2015) . Studies suggest that pericytes are also susceptible to ROS-mediated cellular injury. In ischemic stroke, where BBB dysfunction is directly linked to loss of pericytes, it is triggered by calcium influx mediated by ROS, leading to contraction and death of pericytes (Fernandez-Klett et al. 2013; Hall et al. 2014; Kamouchi et al. 2007 ). In diabetic nephropathy, loss of retinal pericytes is also linked to oxidative stress and ROS, which are induced by hyperglycemia (FerlandMcCollough et al. 2017) . Since pericytes appear to be susceptible to intercellular calcium overload and oxidative stress, it suggests that increased extracellular glutamate level during neuroinflammation might contribute to loss of pericyte coverage in BBB, especially when they become infected by HIV. Our data show that HIV-1 latency increased pericyte susceptibility to inhibitors targeting factors involved in DNA repair indicating that virus latency interferes with DDR in pericytes. The level of γH2AX signaling increased for HIV-1-infected pericytes exposed to glutamate or TNF-α at day 2 post-infection, and correlated with increased reduction in cell population. Higher γH2AX levels in response to glutamate treatment were also observed during latency. Because an increase in γH2AX signaling in cells reflects an increase in a steadystate level of DNA damage, it suggests that HIV-1-infected pericytes are more susceptible to glutamate-induced DNA damage in the brain.
Studies also indicate that brains of patients with rapidly progressive HAND are also characterized by increased loss of astrocytes (Thompson et al. 2001) . Our data indicate that astrocytes are less affected by HIV latency, when compared to pericytes, although increases in γH2AX signaling in latently infected astrocytes in response to glutamate treatment suggest that astrocytes are more susceptible to neuroinflammatory conditions, when they become infected by HIV. Virus interference with cellular DDR would likely affect efficient repairs of glutamate-mediated DNA damages and therefore influencing the survival rate of infected cells in the brain during infection. Analysis of postmortem brain tissue from patients with HIV-associated dementia (HAD), which is the most severe form of HAND, showed that an increased rate of astrocyte loss was associated with an increase in number of HIV DNA-positive astrocytes (Thompson et al. 2001) .
It was determined that HIV infection of pericytes is restricted at the entry, and hence, pericyte infection could be limited in the brain, but it is possible that virus can infect pericytes through other mechanisms. For example, astrocytes are also resistant to infection by cell-free HIV-1, but are efficiently infected via cell-to-cell contact (Luo and He 2015; Nath et al. 1995; Schweighardt and Atwood 2001; Tardieu et al. 1992) . Regardless of how pericytes get infected, they reside in proximity to tight junctions, a pivotal perivascular niche indicated as a major route of virus entry. This localization suggests that the pericytes together with astrocytes, and endothelial cells, are likely the first cells in the brain to become infected by HIV. Depletion of pericytes and astrocytes in brains of patients with HAND may therefore also be caused by HIV infection and establishment of latency. It would also suggest that although pericytes and astrocytes are mediators of neuroinflammation, their DDR become injured by HIV latency and leads to accumulation of DNA damages triggered by neuroinflammation condition, and increased rate of apoptosis, resulting in their depletion in the brain. It would be also important to examine whether HIV latency in pericytes affects formation of functional BBB and maintains its integrity, particularly in response to neuroinflammatory conditions, which are often noted during HIV infection, regardless of cART.
In summary, we demonstrate that the brain vascular pericytes are among the rare brain-derived cells that allow viral latency, which supports the notion that a diverse pool of viral reservoir exists in the CNS of HIV-infected individuals. We also show that the HIV-1 latency renders pericytes vulnerable to the neuroinflammatory conditions that are commonly found in persons with HIV-1. These findings provide an important insight into the establishment of viral reservoirs in the CNS during acute HIV-1 infection and explains the reasons as to why targeting the DNA damage response in latently infected cells would likely support therapeutic approaches to cure HIV/AIDS.
Materials and methods
Ethics statement The Research Subjects Review Board at the University of Rochester Medical Center approved studies involving human samples. All the study participants were adults and blood samples were obtained after written informed consent, in accordance with the Declaration of Helsinki.
Cell cultures and reagents Primary human brain vascular pericytes and human astrocytes were obtained from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultured for additional three passages before used for experiment. The cells were cultured in complete medium provided by the supplier, containing 2% fetal bovine serum (FBS), antibiotics (penicillin and streptomycin), and pericyte or astrocyte growth supplement. Primary central memory T (T CM ) cells were generated from naïve CD4 + T cells isolated from peripheral blood mononuclear cells (PBMC) selected from healthy blood donors, as previously described (Bosque and Planelles 2009; Piekna-Przybylska et al. 2017) . ATM kinase inhibitor (KU55933) and PARP inhibitor I (3-ABA, 3-aminobenzamide) were obtained from Calbiochem. DNA-PK inhibitor (NU7441) was obtained from Apexbio Technology LLC.
Generation of HIV-1 stocks and infection HIV-1-GFP (pNL4-3-deltaE-EGFP) was obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). DHIV was obtained from Vicente Planelles (Bosque and Planelles 2009 ). Plasmid expressing the vesicular stomatitis virus G protein (VSV-G) under the control of the human cytomegalovirus promoter (pHCMV-g) was obtained from Carrie Dykes (Dykes et al. 2010) . Human embryonic kidney 293T cells were used for generation of HIV-1 stocks. 293T cells were maintained in Dulbecco's modified Eagle's medium supplemented with 2 mM L-glutamine, 100 U of penicillin/ml, 100 μg of streptomycin/ml, and 10% heat-inactivated FBS obtained from HyClone. The cells were transiently transfected with 40 μg of HIV-GFP or DHIV, together with 40 μg of pHCMV-g plasmid DNA by lipofection (SuperFect, Qiagen); supernatants were harvested after 72 h and stored at − 80°C. HIV-1 virus capsid protein (p24) quantitation was performed on virus stocks using an ELISA (R&D systems), according to manufacturer's instructions. VSV-G pseudotyped HIV-1 stocks were used to infect pericytes and astrocytes. Briefly, at 80-90% confluency, the cells were exposed to HIV-GFP or DHIV (both at 10 ng/ml of p24) for 24 h. Then, the medium was removed, the cells were washed, and fresh medium was added. To generate latently infected cells, at day 3-4 postinfection, the cells were trypsinized and seeded again. When the cultures reached a confluence of 80-90%, they were seeded again at 40-50% confluence. Generation of latently infected primary memory T cells were done as previously described (Bosque and Planelles 2009; Piekna-Przybylska et al. 2017 ).
Immunocytochemistry At endpoint, cells were washed with PBS, then fixed using 4.2% paraformaldehyde solution (BD Cytofix™ Fixation Buffer) for 15 min, and washed three times with PBS. For intracellular staining, cells were permeabilized with solution containing 0.2% Triton X-100 and 1% BSA. After washing with PBS three times, the cells were blocked for 30 min at room temperature with blocking buffer BD Pharmingen™ Stain Buffer containing FBS. KC57-FITC antibodies (1:50, Coulter Clone) were used for intracellular staining of p24 antigen for 2 h at room temperature. For γH2AX detection, cells were stained with Alexa Fluor 647 Mouse anti-H2AX (pS139) (1:50, BD Pharmingen) for 2 h at room temperature. After staining, the antibody was removed and the wells were washed three times with BD Pharmingen™ Stain Buffer. Nuclei were detected using DAPI or Hoechst stains. For cultures treated with DNA repair inhibitors, cells were collected and counted to seed equal number of cells in new dishes before exposing them to different inhibitors. At endpoint, the cells were washed three times with PBS to remove dead cells, fixed using 4.2% paraformaldehyde solution (BD Cytofix™ Fixation Buffer) for 10 min, and washed three times with PBS. The cells were then stained with DAPI and the density of cells was analyzed by counting nuclei. Olympus IX83 microscope was used for image acquisition from plates at × 10 and × 20 magnification. Quantitative analysis of positively stained cells and total cells was performed using Olympus Cell Sens Dimension software.
Flow cytometry For flow cytometry analysis, the cells were detached enzymatically by standard trypsinization, or mechanically by scraping. For GFP analysis, the cells were washed with PBS and fixed for 15 min using 4.2% paraformaldehyde solution (BD Cytofix™ Fixation Buffer). For analysis of intracellular levels of γH2AX, fixed cells were permeabilized for 5-10 min using BD Phosflow™ Perm Buffer III, then washed three times with PBS and blocked for 20 min with BD Pharmingen™ Stain Buffer. To detect γH2AX, the samples were stained for 1-2 h with specific monoclonal antibodies conjugated to Alexa Fluor® 647 (1:50, BD Pharmingen). Intracellular p24 Gag expression was detected with monoclonal antibody conjugated with FITC (KC57-FITC, Coulter Clone) and analyzed as previously described (Bosque and Planelles 2009 ). Sample fluorescence of 10,000 or 20,000 cells was analyzed by using Accuri C6 (BD Biosciences). Cell populations were analyzed using FlowJo software (Version 10.2). Statistical analysis was performed with GraphPad Prism Software. Statistical analysis was done by one-way ANOVA and Tukey's multiple comparisons post-test (significance P < 0.05).
Integration analysis To detect HIV-1 provirus in host genome, we used the approach described by Liszewski et al. (2009) ). Briefly, genomic DNA was isolated from cells collected at day 11 post-infection using the DNeasy Tissue Kit (Qiagen). Integration of HIV-1 provirus was determined by Alu-gag PCR followed by the nested PCR specific for the 5′-LTR region of HIV-1. For Alu-gag, the pair of primers AluForward (GCC TCC CAA AGT GCT GGG ATT ACA G) and gag-Reverse (GCT CTC GCA CCC ATC TCT CTC C; nucleotides (nt): 803-782) was used for amplification (40 cycles of 95°C for 15 s, 50°C for 15 s, and 72°C for 1 min). Twenty percent of Alu-gag PCR amplification reaction was used in the nested PCR. The pair of primers U3 NF-κ3-Forward (CAT CGA GCT TTC TAC AAG GGA; nt: 333-353) and gagUTR-Reverse (CCA GTC GCC GCC CCT CGC CTC TTG CCG TG; nt: 744-716) was used to amplify 411-ntlong fragment (product A). The pair of primers U3 Sp1-Forward (CTC AGA TGC TAC ATA TAA GCA GCT; nt: 414-437) and gagUTR-Reverse (CCA GTC GCC GCC CCT CGC CTC TTG CCG TG; nt: 744-716) was used to amplify 330-nt-long fragment (product B). The pair of primers R-Forward (CCT GGG AGC TCT CTG GCT AAC T; nt: 482-503) and U5-Reverse (TCC ACA CTG ACT AAA AGG GTC TGA; nt: 622-599) was used to amplify 140-nt-long fragment (product C). The cycling conditions for nested PCR reactions were 40 cycles of 95°C for 15 s, 50°C for 15 s, and 72°C for 30 s. All PCRs were performed using Platinum Taq Polymerase (Thermo Fisher Scientific). 
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